How do I hire a fractional VP of Sales for a biotech company in 2027?

Question

Pulse · Accepted Answer

# How do I hire a fractional VP of Sales for a biotech company in 2027?

## Direct Answer

You hire a fractional VP of Sales by first clarifying whether you need **strategic revenue architecture** (pipeline design, pricing, partner channel setup) or **direct sales execution** (closing institutional accounts, managing a small team). Biotech sales cycles are long, technical, and heavily regulated, so your fractional leader must have domain-specific experience — selling into pharma, diagnostics, or medtech — not just general B2B SaaS chops. Expect to invest 4–8 weeks in vetting, including reference calls with former biotech clients, and budget for a 3–6 month minimum engagement to see meaningful pipeline movement.

```mermaid
flowchart TD
    A[Define Need] --> B{Strategy or Execution?}
    B --> C[Strategy: Pipeline design, pricing, channels]
    B --> D[Execution: Closing deals, team management]
    C --> E[Require biotech domain experience]
    D --> E
    E --> F[Vet candidates: 4–8 weeks]
    F --> G[Reference calls with biotech clients]
    G --> H[Engage: 3–6 month minimum]
    H --> I[Review pipeline progress at 90 days]
```

```steps
title: How to hire a fractional VP of Sales for a biotech company in 2027
- Define the scope | Decide if you need strategy-only (pipeline design, pricing, partner channel setup) or hands-on closing (direct deal execution, team management)
- Identify domain fit | Require prior biotech, pharma, or medtech sales experience — not just general B2B SaaS
- Conduct structured interviews | Ask for a specific biotech sales process they designed, a deal they closed, and a team they built
- Check references with biotech clients | Call 2–3 former clients who had similar stage and complexity
- Negotiate terms | Set a 3–6 month minimum, define days per month (10–20), and agree on equity if pre-revenue
```

```compare
a: Fractional VP of Sales (2027 biotech)
b: Full-time VP of Sales (2027 biotech)
- Cost | a retainer + 0.25–1.0% equity | 180k–250k salary + 30–50% bonus + 1–3% equity
- Commitment | 10–20 days/month, 3–6 month minimum | Full-time, indefinite
- Speed to impact | 2–4 weeks to assess and act | 4–8 weeks to onboard and hire
- Risk | Low (terminable with 30-day notice) | High (severance, cultural disruption)
- Best for | Pre-revenue to 5M ARR, uncertain market fit | 5M+ ARR, proven product, scaling team
```

```callout
type: tip
Biotech buyers (CROs, pharma procurement, academic centers) often require a technical sales conversation. If your fractional VP can't speak the language — assay validation, regulatory pathways, reimbursement codes — they will lose credibility fast. Prioritize domain fluency over generic sales swagger.
```

## Why Biotech Sales Is Different in 2027

Biotech sales in 2027 is not a volume game. You are not selling a subscription SaaS product. You are selling a platform, a reagent, a diagnostic tool, or a therapeutic service that costs tens of thousands per contract and involves **multiple stakeholders**: R&D scientists, procurement officers, legal teams, and sometimes regulatory bodies. The buying cycle is **measured in months, not weeks**, and trust is built through technical credibility, not cold email sequences.

A fractional VP of Sales who comes from a pure SaaS background will likely fail here. They will push for high-velocity outbound tactics that alienate scientific buyers. They will misprice your offering because they don't understand the **cost of goods sold** in a regulated environment. They will hire the wrong kind of sales reps — people who can close a CRM deal but can't explain a Western blot.

Your fractional leader must have **direct experience** selling to biotech buyers. That means they have navigated **institutional review boards**, **material transfer agreements**, and **multi-year procurement cycles**. They have managed **channel partners** like distributors or CROs. They have built **pricing models** that account for volume discounts, academic vs. commercial pricing, and subscription vs. perpetual licenses.

![How do I hire a fractional VP of Sales for a biotech company in 2027 — figure 1](/assets/qa/tl13924-b1.jpg)

## What to Look for in a Fractional VP of Sales

When you interview candidates, focus on three specific competencies:

**1. Pipeline architecture for long cycles.** Ask them: "How do you build a pipeline when the average deal takes 9 months?" A good answer includes **lead scoring** based on buyer stage (awareness, evaluation, procurement), **nurture sequences** that provide technical value (white papers, webinars, peer-reviewed data), and **forecasting methods** that account for slippage. They should name tools like **Salesforce** or **HubSpot** for pipeline management, but they should not claim a specific win rate — that's fabricated.

![How do I hire a fractional VP of Sales for a biotech company in 2027 — figure 2](/assets/qa/tl13924-b2.jpg)

**2. Pricing and packaging for biotech.** Ask them: "How do you price a pro

Kory White

How do I hire a fractional VP of Sales for a biotech company in 2027?

Why Biotech Sales Is Different in 2027

What to Look for in a Fractional VP of Sales

The Cost Breakdown: What You Actually Pay

How to Evaluate Success in the First 90 Days

When to Choose a Fractional VP vs. a Full-Time Hire

FAQ

Sources

Related on PULSE

Kory White

How do I hire a fractional VP of Sales for a biotech company in 2027?

Why Biotech Sales Is Different in 2027

What to Look for in a Fractional VP of Sales

The Cost Breakdown: What You Actually Pay

How to Evaluate Success in the First 90 Days

When to Choose a Fractional VP vs. a Full-Time Hire

FAQ

Sources

Related on PULSE

Two scores — Gate vs IQ